 | C4 Therapeutics, Inc. | |||
| NasdaqGS : CCCC || Location: United States | ||||
$11.66-0.58 (-4.74%) |
0.3 M | 11.325 - 12.14 | ||
| Last Updated:08/09/2022 15:11 | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| July 15, 2022 | 5.224 M |
| June 30, 2022 | 5.075 M |
| June 15, 2022 | 4.212 M |
| May 31, 2022 | 4.295 M |
| May 13, 2022 | 3.897 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2022 | -0.58 | -0.65 | -12.10% |
| 12/31/2021 | -0.58 | -0.31 | 46.60% |
| 09/30/2021 | -0.59 | -0.51 | 13.60% |
| 06/30/2021 | -0.59 | -0.51 | 13.60% |
| 03/31/2021 | -0.63 | -0.49 | 22.20% |
CCCC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 48.797M | Shares Float | 34.895M |
| Short Float | 5.224M | Market Cap | 623.14M |
| Institution ownership | 93.65% | Insider ownership | 11.261% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -1.99 | Forward EPS | -3.27 |